News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
681,648 Results
Type
Article (49659)
Company Profile (434)
Press Release (631538)
Multimedia
Podcasts (153)
Webinars (19)
Section
Business (180282)
Career Advice (3147)
Deals (32650)
Drug Delivery (120)
Drug Development (80810)
Employer Resources (177)
FDA (15738)
Job Trends (13824)
News (315799)
Policy (30234)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2747)
Academic (1)
Accelerated approval (32)
Adcomms (36)
Allergies (140)
Alliances (46073)
ALS (175)
Alzheimer's disease (1739)
Antibody-drug conjugate (ADC) (334)
Approvals (15941)
Artificial intelligence (525)
Autoimmune disease (161)
Automation (33)
Bankruptcy (309)
Best Places to Work (11153)
BIOSECURE Act (19)
Biosimilars (186)
Biotechnology (310)
Bladder cancer (158)
Brain cancer (64)
Breast cancer (650)
Cancer (4901)
Cardiovascular disease (426)
Career advice (2677)
Career pathing (39)
CAR-T (307)
CDC (46)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (34)
Clinical research (68845)
Collaboration (1754)
Company closure (5)
Compensation (1129)
Complete response letters (69)
COVID-19 (2662)
CRISPR (98)
C-suite (830)
Cystic fibrosis (154)
Data (6229)
Decentralized trials (2)
Denatured (46)
Depression (144)
Diabetes (513)
Diagnostics (6178)
Digital health (41)
Diversity (10)
Diversity, equity & inclusion (44)
Drug discovery (267)
Drug pricing (192)
Drug shortages (33)
Duchenne muscular dystrophy (241)
Earnings (74223)
Editorial (65)
Employer branding (22)
Employer resources (158)
Events (116315)
Executive appointments (943)
FDA (18800)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1498)
Gene editing (213)
Generative AI (48)
Gene therapy (673)
GLP-1 (1032)
Government (4610)
Grass and pollen (7)
Guidances (361)
Healthcare (18503)
HIV (61)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (277)
Immuno-oncology (58)
Indications (101)
Infectious disease (2917)
Inflammatory bowel disease (201)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (247)
Interviews (612)
IPO (15672)
IRA (52)
Job creations (3053)
Job search strategy (2169)
JPM (68)
Kidney cancer (14)
Labor market (80)
Layoffs (549)
Leadership (39)
Legal (6770)
Liver cancer (92)
Longevity (15)
Lung cancer (651)
Lymphoma (376)
Machine learning (41)
Management (63)
Manufacturing (797)
MASH (171)
Medical device (12685)
Medtech (12734)
Mergers & acquisitions (18064)
Metabolic disorders (1334)
Multiple sclerosis (156)
NASH (22)
Neurodegenerative disease (341)
Neuropsychiatric disorders (98)
Neuroscience (3020)
Neurotech (1)
NextGen: Class of 2026 (6473)
Non-profit (4420)
Now hiring (48)
Obesity (637)
Opinion (324)
Ovarian cancer (166)
Pain (210)
Pancreatic cancer (220)
Parkinson's disease (293)
Partnered (34)
Patents (484)
Patient recruitment (486)
Peanut (56)
People (54123)
Pharmaceutical (77)
Pharmacy benefit managers (29)
Phase 1 (21611)
Phase 2 (30377)
Phase 3 (22707)
Pipeline (5078)
Policy (306)
Postmarket research (2405)
Preclinical (9139)
Press Release (72)
Prostate cancer (247)
Psychedelics (55)
Radiopharmaceuticals (298)
Rare diseases (909)
Real estate (5424)
Recruiting (74)
Regulatory (23303)
Reports (40)
Research institute (2452)
Resumes & cover letters (504)
Rett syndrome (28)
RNA editing (21)
RSV (73)
Schizophrenia (157)
Series A (249)
Series B (195)
Service/supplier (9)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (166)
Sponsored (46)
Startups (3399)
State (2)
Stomach cancer (19)
Supply chain (102)
Tariffs (83)
The Weekly (106)
Vaccines (967)
Venture capital (95)
Weight loss (427)
Women's health (76)
Worklife (22)
Date
Last 7 days (606)
Last 30 days (2120)
Last 365 days (30324)
2026 (2870)
2025 (30760)
2024 (35340)
2023 (39803)
2022 (50524)
2021 (54811)
2020 (52577)
2019 (45157)
2018 (34178)
2017 (31795)
2016 (31309)
2015 (36389)
2014 (28868)
2013 (23700)
2012 (24928)
2011 (25692)
2010 (23830)
Location
Africa (888)
Alabama (84)
Alaska (6)
Arizona (252)
Arkansas (14)
Asia (39382)
Australia (6789)
California (11030)
Canada (3201)
China (1126)
Colorado (450)
Connecticut (464)
Delaware (328)
Europe (90970)
Florida (1626)
Georgia (343)
Hawaii (3)
Idaho (55)
Illinois (843)
India (65)
Indiana (472)
Iowa (20)
Japan (420)
Kansas (120)
Kentucky (37)
Louisiana (27)
Maine (72)
Maryland (1290)
Massachusetts (8247)
Michigan (319)
Minnesota (614)
Mississippi (5)
Missouri (131)
Montana (31)
Nebraska (25)
Nevada (112)
New Hampshire (76)
New Jersey (2941)
New Mexico (31)
New York (2901)
North Carolina (1489)
North Dakota (9)
Northern California (5353)
Ohio (324)
Oklahoma (21)
Oregon (40)
Pennsylvania (2236)
Puerto Rico (19)
Rhode Island (46)
South America (1180)
South Carolina (61)
Southern California (4291)
Tennessee (149)
Texas (1685)
United States (39356)
Utah (310)
Virginia (253)
Washington D.C. (72)
Washington State (939)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
681,648 Results for "the emmes corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emmes Group® names Germaine Gross Chief Commercial Officer of Emmes® Biopharma
January 16, 2025
·
3 min read
Business
Navigating Funding Freezes and AI Frontiers
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis discusses key themes from BIO and DIA, including the funding environment, with Rich Daly, CEO of Catalyst Pharmaceuticals, Peter Ronco, CEO of Emmes Corporation, and Phil Vanek, founder of Redline Bio Advisors.
June 20, 2025
·
1 min read
·
Lori Ellis
Press Releases
Lyra Therapeutics Provides Corporate Update
January 12, 2026
·
4 min read
Emmes Acquires VaxTRIALS
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation
October 5, 2023
·
3 min read
Press Releases
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
January 13, 2026
·
7 min read
Press Releases
Compass Therapeutics Provides Corporate Update
January 6, 2026
·
9 min read
Press Releases
Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026
January 6, 2026
·
7 min read
Press Releases
Decoy Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
February 5, 2026
·
4 min read
Press Releases
Travere Therapeutics Provides Corporate Update and 2026 Outlook
January 13, 2026
·
17 min read
Press Releases
Akari Therapeutics to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
February 5, 2026
·
6 min read
1 of 68,165
Next
